Score Breakdown
Offering Ability
60
Cash Runway
95
Float Risk—
Warrant Exposure
40
Convertible Debt
15
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 43%
💰 Capital Raise
model 55%
• Critical: only 0.4 months cash remaining
🔄 Reverse Split
model est. 45%
• 50-day avg $1.36 approaching $1 threshold
• Only 0 months cash — financial pressure
📉 Score Deterioration
model 10%
• Score in HIGH risk zone (65/100)
Market Data
Market Cap$290.62M
Shares Outstanding331.21M
FloatN/A
Cash$909.0K
Debt$5.80M
Short InterestN/A
Institutional Holdings
Institutional data not yet available.
Short Interest
Short Interest38.5K
Days to Cover3.7
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2024-09-30
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual RNLXY Dilution Snapshot
Renalytix Plc (RNLXY) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for RNLXY: xbrl on 2024-09-30.
- Score coverage note: Float Risk is excluded because public-float data is unavailable.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:
📖 Dilution Education
Score Coverage Note
- Float Risk is excluded because public-float data is unavailable.